Baines Helen, Nwagwu Margaret O, Hastie Graham R, Wiles Roman A, Mayhew Terry M, Ebling Francis Jp
School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Reprod Biol Endocrinol. 2008 Jan 29;6:4. doi: 10.1186/1477-7827-6-4.
The hypogonadal (hpg) mouse is widely used as an animal model with which to investigate the endocrine regulation of spermatogenesis. Chronic treatment of these GnRH-deficient mice with estradiol is known to induce testicular maturation and restore qualitatively normal spermatogenesis. The aim of the current studies was to investigate whether these effects of estradiol are direct effects in the testis, or indirect actions via paradoxical stimulation of FSH secretion from the pituitary gland.
Initially, Western blot and immunohistochemistry were used to analyse tissues from hpg mice to identify potential sites of action of estradiol. In the main study, hpg mice were treated for 50 days with either an estradiol implant or daily injections of recombinant human FSH, or a combination of both, to determine whether estradiol would have an additive or synergistic effect with FSH on testis development, as assessed by histological analysis and stereological quantification of Leydig, Sertoli and germ cell proliferation.
Western blot analysis revealed ERalpha immunoreactive bands of appropriate molecular weight in extracts of testis and pituitary glands from hpg mice, and immunohistochemical studies confirmed ERalpha in nuclei of anterior pituitary cells and Leydig and peritubular cells in hpg mice. Histological and morphometric analyses revealed that estradiol treatment alone was as effective as FSH in promoting Sertoli cell production and proliferation of the seminiferous epithelium, resulting in the production of elongating spermatids. Combined estradiol and FSH treatment did not produce a greater effect than either treatment alone, though an increased dose of FSH significantly increased seminiferous tubule volume and testis weight and increase Sertoli cell numbers further within the same time frame. In contrast, estradiol caused substantial increases in the wet weight of the seminal vesicles, whereas FSH was without effect on this tissue, and did not augment the actions of estradiol.
As ERalpha receptor is abundantly expressed in the pituitary gland of hpg mice, and estradiol did not exert effects on testis development over and above those of FSH, we conclude that the action of estradiol on testis development in hpg mice is predominantly via the stimulation of pituitary FSH release.
性腺功能减退(hpg)小鼠被广泛用作研究精子发生的内分泌调节的动物模型。已知用雌二醇长期治疗这些促性腺激素释放激素(GnRH)缺乏的小鼠可诱导睾丸成熟并在质量上恢复正常的精子发生。当前研究的目的是调查雌二醇的这些作用是对睾丸的直接作用,还是通过反常刺激垂体分泌促卵泡激素(FSH)的间接作用。
最初,使用蛋白质免疫印迹法和免疫组织化学分析hpg小鼠的组织,以确定雌二醇的潜在作用位点。在主要研究中,hpg小鼠用雌二醇植入物或每日注射重组人FSH或两者组合进行50天治疗,以确定雌二醇与FSH对睾丸发育是否具有相加或协同作用,通过组织学分析以及对睾丸间质细胞、支持细胞和生殖细胞增殖的体视学定量来评估。
蛋白质免疫印迹分析显示hpg小鼠睾丸和垂体提取物中存在适当分子量的雌激素受体α(ERα)免疫反应条带,免疫组织化学研究证实hpg小鼠垂体前叶细胞、睾丸间质细胞和睾丸周细胞的细胞核中有ERα。组织学和形态计量学分析显示,单独使用雌二醇治疗在促进支持细胞产生和生精上皮增殖方面与FSH一样有效,从而产生伸长的精子细胞。雌二醇和FSH联合治疗没有比单独任何一种治疗产生更大的效果,不过在相同时间范围内增加FSH剂量可显著增加生精小管体积和睾丸重量,并进一步增加支持细胞数量。相比之下,雌二醇使精囊湿重大幅增加,而FSH对该组织没有影响,也没有增强雌二醇的作用。
由于ERα受体在hpg小鼠的垂体中大量表达,且雌二醇对睾丸发育的作用不超过FSH,我们得出结论,雌二醇对hpg小鼠睾丸发育的作用主要是通过刺激垂体FSH释放。